Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0000899243-22-024006

Director acquired 80,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Huang James Director 2022-06-22 Grant or award +80,000 188,333 D
Derivatives
Huang James Director 2022-06-22 Grant or award · Employee Stock Option (right to buy) +100,000 100,000 D
Loading xslF345X03/doc4.xml…